(Q69782430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

J R Corvalan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

W Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

V A Gore

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

D R Brandon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

P J Ryde

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

138-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829048%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00205591

5 October 2019

exact match

0 references

cites work

Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen

1 reference

12 December 2020

Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids

1 reference

12 December 2020

Studies of methotrexate-monoclonal antibody conjugates for immunotherapy

1 reference

12 December 2020

Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograft

1 reference

12 December 2020

Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

1 reference

12 December 2020

Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells

1 reference

12 December 2020

Antitumor properties of vindesine-monoclonal antibody conjugates

1 reference

12 December 2020

Experimental tumoricidal effects of monoclonal antibody against solid breast tumors

1 reference

12 December 2020

A comparison of the content and immunohistochemical patterns of CEA-like activity in human colorectal tumours and nude mouse xenografts

1 reference

12 December 2020